AG
RMD icon

Ascent Group’s ResMed RMD Stock Holding History

Ascent Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$307K Sell
1,366
-917
-40% -$229K 0.01% 619
2025
Q4 		$550K Sell
2,283
-9
-0.4% -$2.3K 0.02% 477
2025
Q3 		$627K Sell
2,292
-455
-17% -$124K 0.02% 448
2025
Q2 		$709K Buy
2,747
+14
+0.5% +$3.34K 0.03% 400
2025
Q1 		$612K Buy
2,733
+33
+1% +$7.7K 0.03% 409
2024
Q4 		$617K Sell
2,700
-224
-8% -$53.9K 0.05% 343
2024
Q3 		$714K Buy
2,924
+48
+2% +$10.7K 0.05% 328
2024
Q2 		$551K Buy
2,876
+207
+8% +$42K 0.04% 347
2024
Q1 		$529K Sell
2,669
-760
-22% -$139K 0.05% 342
2023
Q4 		$626K Buy
3,429
+339
+11% +$52.1K 0.06% 311
2023
Q3 		$443K Sell
3,090
-886
-22% -$160K 0.05% 331
2023
Q2 		$713K Buy
3,976
+549
+16% +$122K 0.08% 272
2023
Q1 		$750K Buy
3,427
+1,465
+75% +$318K 0.08% 264
2022
Q4 		$408K Sell
1,962
-33
-2% -$7.25K 0.05% 330
2022
Q3 		$446K Buy
1,995
+45
+2% +$10.2K 0.05% 309
2022
Q2 		$469K Sell
1,950
-286
-13% -$60.9K 0.06% 305
2022
Q1 		$542K Buy
2,236
+368
+20% +$89K 0.06% 287
2021
Q4 		$439K Buy
+1,868
New +$485K 0.06% 315

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ascent Group's RMD Position: Q1 2026 in Review

Ascent Group reduced its ResMed (RMD) stake by 40% in Q1 2026, selling an estimated $229K and leaving 1,366 shares worth $307K. The position accounts for 0.01% of the portfolio, ranked #619.

Ascent Group first reported a position in RMD in Q4 2021 and has held it in 18 quarters since. The position peaked at $750K in Q1 2023. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Ascent Group held 1,366 shares of ResMed worth $307K as of Q1 2026.
  • Ascent Group sold 917 ResMed shares in Q1 2026, an estimated $229K.
  • ResMed made up 0.01% of Ascent Group's portfolio in Q1 2026, its #619 holding.
  • Ascent Group first reported a position in ResMed in Q4 2021 and has held it in 18 quarters since.
  • Ascent Group's ResMed position peaked at $750K in Q1 2023.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Ascent Group's 13F filing for Q1 2026, filed 15 May 2026.